Lattice_grid_med
Powered by LatticeGrid

Search Enter term and hit return. Use '*' for as a wildcard.

Publication Listing for the MeSH term TUMORS. Found 16 abstracts

Chen DY, Uzzo RG, Viterbo R. Thinking beyond surgery in the management of renal cell carcinoma: the risk to die from renal cell carcinoma and competing risks of death. [Review]. World journal of urology. 2014 Jun;32(3):607-13.   PMCID: No NIH funding
Garcia JA, Hudes GR, Choueiri TK, Stadler WM, Wood LS, Gurtler J, Bhatia S, Joshi A, Hozak RR, Xu YH, Schwartz JD, Thompson JA. A Phase 2, Single-Arm Study of Ramucirumab in Patients With Metastatic Renal Cell Carcinoma With Disease Progression on or Intolerance to Tyrosine Kinase Inhibitor Therapy. Cancer. 2014 Jun;120(11):1647-55.   PMCID: No NIH funding
Melnikov A, Scholtens D, Godwin A, Levenson V. Differential Methylation Profile of Ovarian Cancer in Tissues and Plasma. Journal of Molecular Diagnostics. 2009 Jan;11(1):60-5.   PMCID: PMC2607567
Rusthoven KE, Kavanagh BD, Cardenes H, Stieber VW, Burri SH, Feigenberg SJ, Chidel MA, Pugh TJ, Franklin W, Kane M, Gaspar LE, Schefter TE. Multi-Institutional Phase I/II Trial of Stereotactic Body Radiation Therapy for Liver Metastases. Journal of Clinical Oncology. 2009 Apr;27(10):1572-8.   PMCID: not NIH funded
Adjei AA, Cohen RB, Franklin W, Morris C, Wilson D, Molina JR, Hanson LJ, Gore L, Chow L, Leong S, Maloney L, Gordon G, Simmons H, Marlow A, Litwiler K, Brown S, Poch G, Kane K, Haney J, Eckhardt SG. Phase I pharmacokinetic and pharmacodynamic study of the oral, small-molecule mitogen-activated protein kinase kinase 1/2 inhibitor AZD6244 (ARRY-142886) in patients with advanced cancers. Journal of Clinical Oncology. 2008 May;26(13):2139-46.
Blay JY, von Mehren M, Samuels BL, Fanucchi MP, Ray-Coquard I, Buckley B, Gilles L, Lebedinsk C, Elsayed YA, Le Cesne A. Phase I Combination Study of Trabectedin and Doxorubicin in Patients with Soft-Tissue Sarcoma. Clinical Cancer Research. 2008 Oct;14(20):6656-62.
Cohen EE, Rosen LS, Vokes EE, Kies MS, Forastiere AA, Worden FP, Kane MA, Sherman E, Kim S, Bycott P, Tortorici M, Shalinsky DR, Liau KF, Cohen RB. Axitinib is an active treatment for all histologic subtypes of advanced thyroid cancer: Results from a phase II study. Journal of Clinical Oncology. 2008 Oct;26(29):4708-13.
Ross A, Mehdizadeh S, Tokar J, Leighton JA, Kamal A, Chen A, Schembre D, Chen G, Binmoeller K, Kozarek R, Waxman I, Dye C, Gerson L, Harrison ME, Haluszka O, Lo S, Semrad C. Double balloon enteroscopy detects small bowel mass lesions missed by capsule endoscopy. Digestive diseases and sciences. 2008 Aug;53(8):2140-3.
Armstrong DK, Bookman MA, McGuire W, Bristow RE, Schilder JM. A phase I study of paclitaxel, topotecan, cisplatin and Filgrastim in patients with newly diagnosed advanced ovarian epithelial malignancies: A Gynecologic Oncology Group study. Gynecologic Oncology. 2007 Jun;105(3):667-71.
Balogh GA, Heulings R, Mailo D, Wang R, Li YS, Hardy R, Russo J. Methodological approach to study the genomic profile of the human breast. International Journal of Oncology. 2007 Aug;31(2):253-60.
Chakravarti A, DeSilvio M, Zhang M, Grignon D, Rosenthal S, Asbell SO, Hanks G, Sandler HM, Khor LY, Pollack A, Shipley W. Prognostic value of p16 in locally advanced prostate cancer: A study based on radiation therapy oncology group protocol 9202. Journal of Clinical Oncology. 2007 Jul;25(21):3082-9.
Torres-Roca JF, DeSilvio M, Mora LB, Khor LY, Hammond E, Ahmad N, Jove R, Forman J, Lee RJ, Sandier H, Pollack A. Activated STAT3 as a correlate of distant metastasis in prostate cancer: A secondary analysis of radiation therapy oncology group 86-10. Urology. 2007 Mar;69(3):505-9.
Burrows JF, Chanduloy S, McIlhatton MA, Nagar H, Yeates K, Donaghy P, Price J, Godwin AK, Johnston PG, Russell SH. Altered expression of the septin gene, SEPT9, in ovarian neoplasia. Journal of Pathology. 2003 Dec;201(4):581-8.
Price RA, Murphy S, McNeeley SW, Charlie CM, Horwitz E, Movsas B, Raben A, Pollack A. A method for increased dose conformity and segment reduction for sMLC delivered IMRT treatment of the prostate. International Journal of Radiation Oncology Biology Physics. 2003 Nov;57(3):843-52.
Hohaus S, Cavallo S, Bellacosa A, Genuardi M, Galli J, Cadoni G, Almadori G, Lauriola L, Litwin S, Maurizi M, Neri G. Telomerase activity in human laryngeal squamous cell carcinomas. Clinical Cancer Research. 1996 Nov;2(11):1895-900.
Bellacosa A, Defeo D, Godwin AK, Bell DW, Cheng JQ, Altomare DA, Wan MH, Dubeau L, Scambia G, Masciullo V, Ferrandina G, Panici PB, Mancuso S, Neri G, Testa JR. MOLECULAR ALTERATIONS OF THE AKT2 ONCOGENE IN OVARIAN AND BREAST CARCINOMAS. International journal of cancer. 1995 Aug;64(4):280-5.
The above publications are sorted by year, faculty last name, and first author. Click on any highlighted author listed to find all publications attributed to that individual. Click on the publication title to see the abstract. First authors who are faculty are highlighted like this. Last authors who are faculty are highlighted like this. Other authors who are faculty are highlighted like this.

MeSH cloud from publications including the MeSH term TUMORS

TUMORS CANCER EXPRESSION CARCINOMA SURVIVAL ANDROGEN DEPRIVATION KeyWords Plus: GROWTH HEAD DNA PROTEIN TRIAL ANTITUMOR-ACTIVITY RADIOTHERAPY BREAST III TRIAL CARCINOMAS LASER CAPTURE MICRODISSECTION RESECTION MYC methylation IMRT ANGIOGENESIS KIDNEY CANCER renal cell carcinoma ASSOCIATION CONTINUOUS INTRAVENOUS-INFUSION E2F PATHWAY BREAST-CANCER RISING REGION MEK INHIBITOR INTENSITY-MODULATED RADIOTHERAPY phase 2 ROLES peritoneal cancer FACTOR EXPRESSION Urology & Nephrology GENES OVEREXPRESSION ramucirumab COLON INCIDENCE DISEASE CARBOPLATIN NECK LUNG ARRAYS monoclonal BRCA1 PATHWAY PROGRESSION CA125 small bowel enteroscopy-neoplasm-obscure gastrointestinal bleeding TRANSCRIPTION-3 SELECTION Oncology breast laser capture microdissection-microarray-PCR amplification-linear amplification metastatic PROMOTER ULTRASOUND YIELD CDCREL-1 INFANT MUTATIONS alternative splicing ACUTE MYELOID-LEUKEMIA SUNITINIB SEQUENCES conformal prostate irradiation Prognostic measurement CO-MORBIDITY INHIBITION CAPILLARIES SORAFENIB ECTEINASCIDIN-743 ET-743 Renal cell carcinoma ACTIVE SURVEILLANCE IN-SITU epithelial ovarian cancer EUROPEAN-ORGANIZATION SMOKING Medical decision making OLIGONUCLEOTIDE MICROARRAY ANALYSIS AMPLIFICATION MODEL CHARLSON COMORBIDITY INDEX ovarian carcinoma LOCALIZATION COMPOUND SBRT STATISTICS PLANS LEUKEMIA GROUP-B TRANSCRIPTS Nomogram RADIATION-THERAPY P53 GENE RB SOLID MALIGNANCIES paclitaxel VITRO MLL NATURAL-HISTORY sMLC GROWTH-FACTOR VEGF ENDOTHELIAL GROWTH-FACTOR NECK-CANCER MASSES MAMMALIAN SEPTINS PROGNOSTIC-FACTORS STAGE-III CELL GENE-EXPRESSION PROFILES antibody septin gene transcripts SEER VALIDATION CELLS LESIONS POLYMERASE CHAIN-REACTION APOPTOSIS REGRESSION POTENT Comorbidity LUNG-CANCER PULL ENTEROSCOPY BEVACIZUMAB VIVO SMALL-INTESTINE PUTATIVE ONCOGENE MINOR-GROOVE
Last updated on Saturday, August 15, 2020